TXMD
TherapeuticsMD Inc
NASDAQ: TXMD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.04
-3.32% today
Updated 2026-04-30
Market cap
$24.31M
P/E ratio
—
P/S ratio
8.04x
EPS (TTM)
$-0.06
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
TherapeuticsMD Inc (TXMD) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
+33.9%
Most recent quarter
EPS YoY growth
-100.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-5.6%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-10.4%
2026-03-27
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-27 | $0.00 | — | $2.22 | $1.99 | -10.4% |
| 2025-11-12 | $0.00 | — | $1.64 | $1.62 | -0.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 | $0.00 | — | $893000.00 | +33.9% |
| 2025-09-30 | $0.00 | $0.00 | — | $784000.00 | +43.3% |
| 2025-06-30 | $0.00 | $0.05 | — | $952000.00 | +306.8% |
| 2025-03-31 | — | $0.02 | — | $393000.00 | +25.6% |
| 2024-12-31 | $0.04 | $0.02 | -45.3% | $667000.00 | +32.9% |
| 2024-09-30 | $0.04 | $-0.05 | -232.0% | $547000.00 | -1132.1% |
| 2024-06-30 | $0.03 | $-0.09 | -415.0% | $234000.00 | -46.5% |
| 2024-03-31 | $0.03 | $-0.08 | -355.3% | $313000.00 | -72.8% |
| 2023-12-31 | $-0.13 | $-0.08 | +38.5% | $502000.00 | — |
| 2023-09-30 | $-0.05 | $-0.32 | -540.0% | $-53000.00 | — |
| 2023-06-30 | $-0.07 | $-0.24 | -242.9% | $437000.00 | — |
| 2023-03-31 | $0.06 | $-0.37 | -716.7% | $1.15M | — |
Frequently asked questions
Has TherapeuticsMD Inc beaten earnings estimates?
TherapeuticsMD Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports.
How does TXMD stock react to earnings?
TXMD stock has moved an average of -5.6% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is TherapeuticsMD Inc's revenue growth rate?
TherapeuticsMD Inc reported year-over-year revenue growth of +33.9% in its most recent quarter, with EPS growing -100.0% year-over-year.